These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31793026)

  • 1. Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy.
    Wu JJ; Zhao L; Hu HG; Li WH; Li YM
    Med Res Rev; 2020 May; 40(3):1117-1141. PubMed ID: 31793026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of small molecule inhibitors/agonists targeting STING for disease.
    Liu K; Lan Y; Li X; Li M; Cui L; Luo H; Luo L
    Biomed Pharmacother; 2020 Dec; 132():110945. PubMed ID: 33254439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists and Inhibitors of the cGAS-STING Pathway.
    Yu X; Cai L; Yao J; Li C; Wang X
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING activation in cancer immunotherapy.
    Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
    Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.
    Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ
    Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
    Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
    Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pam
    Hu HG; Wu JJ; Zhang BD; Li WH; Li YM
    Bioconjug Chem; 2020 Nov; 31(11):2499-2503. PubMed ID: 33147965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cGAS-STING, an important pathway in cancer immunotherapy.
    Jiang M; Chen P; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; Ye L; He Y; Zhou C
    J Hematol Oncol; 2020 Jun; 13(1):81. PubMed ID: 32571374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
    Xie X; Liu J; Wang X
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Non-Nucleotide Small-Molecule STING Agonists
    Cherney EC; Zhang L; Lo J; Huynh T; Wei D; Ahuja V; Quesnelle C; Schieven GL; Futran A; Locke GA; Lin Z; Monereau L; Chaudhry C; Blum J; Li S; Fereshteh M; Li-Wang B; Gangwar S; Pan C; Chong C; Zhu X; Posy SL; Sack JS; Zhang P; Ruzanov M; Harner M; Akhtar F; Schroeder GM; Vite G; Fink B
    J Med Chem; 2022 Feb; 65(4):3518-3538. PubMed ID: 35108011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING Signaling in Cancer Cells: Important or Not?
    Sokolowska O; Nowis D
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonated Perylene as Three-in-One STING Agonist for Cancer Chemo-Immunotherapy.
    Zhao X; Zheng R; Zhang B; Zhao Y; Xue W; Fang Y; Huang Y; Yin M
    Angew Chem Int Ed Engl; 2024 Mar; 63(11):e202318799. PubMed ID: 38230819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy.
    Motedayen Aval L; Pease JE; Sharma R; Pinato DJ
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33081170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
    Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
    J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.
    Dejmek M; Šála M; Brazdova A; Vanekova L; Smola M; Klíma M; Břehová P; Buděšínský M; Dračínský M; Procházková E; Zavřel M; Šimák O; Páv O; Boura E; Birkuš G; Nencka R
    Structure; 2022 Aug; 30(8):1146-1156.e11. PubMed ID: 35690061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists.
    Vavřina Z; Perlíková P; Milisavljević N; Chevrier F; Smola M; Smith J; Dejmek M; Havlíček V; Buděšínský M; Liboska R; Vaneková L; Brynda J; Boura E; Řezáčová P; Hocek M; Birkuš G
    J Med Chem; 2022 Oct; 65(20):14082-14103. PubMed ID: 36201304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of STING agonists for cancer immunotherapy.
    Wang J; Meng F; Yeo Y
    Curr Opin Biotechnol; 2024 Jun; 87():103105. PubMed ID: 38461748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2',4'-LNA-Functionalized 5'-S-Phosphorothioester CDNs as STING Agonists.
    Yeboah SK; Zigli A; Sintim HO
    Chembiochem; 2024 Jul; 25(13):e202400321. PubMed ID: 38720428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming STING Agonists Barriers: Peptide, Protein, and Biomembrane-based Biocompatible Delivery Strategies.
    Zheng YF; Wu JJ
    Chem Asian J; 2022 Mar; 17(6):e202101400. PubMed ID: 35080118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING, a promising target for small molecular immune modulator: A review.
    Liu Y; Lu X; Qin N; Qiao Y; Xing S; Liu W; Feng F; Liu Z; Sun H
    Eur J Med Chem; 2021 Feb; 211():113113. PubMed ID: 33360799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.